Latest News

The treatment of patients with the antibody Adrecizumab after cardiogenic shock has no clinical benefit. Promising results from previous studies could not be further substantiated in the clinical trial with 150 study participants. The study was published in the journal The Lancet...

Why not just cut up the virus and render it harmless in this way? That is the idea for a new type of antiviral therapy. The first results in the Petri dish and the animal model are promising. Scientists from Göttingen and Hanover will receive 700,000 euros from the Federal Agency...

If the “ecosystem” of the intestinal bacteria, the so-called microbiome, is changed by drugs, this can have good and bad consequences. Researchers from several European countries want to find out how certain cardiovascular diseases and the microbiome influence each other - and...

Even at a distance of three meters, it takes less than five minutes for an unvaccinated person standing in the breath of a Covid-19-infected person to become infected, with almost 100 percent certainty. However, if both people wear well-fitting medical, or better yet, FFP2 masks,...

Should the tricuspid valve be treated at the same time as the mitral valve reconstruction? In cases of mild tricuspid valve insufficiency, cardiac surgery guidelines have not provided a clear answer. A transatlantic study now published in the New England Journal of Medicine and...

Heart failure with preserved ejection fraction was previously considered largely untreatable. An MDC team led by Professor Michael Gotthardt has now succeeded for the first time in improving cardiac function with the help of a synthetic nucleic acid, as the researchers report in...

In patients with heart failure, the heart can no longer pump a sufficient volume of blood around the body. Treatment options for a specific type of heart failure – known as ‘heart failure with preserved ejection fraction’ (HFpEF) – remain extremely limited, mainly because much...

Prof. Jeanette Erdmann from the German Center for Cardiovascular Research (DZHK) and the University of Lübeck receives the "BIH Excellence Award for Sex and Gender Aspects in Health Research 2021" from the Berlin Institute of Health (BIH) in the Charité. Together with two BIH...

The past studies situation was paradoxical: According to the finding, people who did not drink alcohol at all were to have a shorter life expectancy than people who occasionally drink a glass of wine or a beer. However, a study from Greifswald is now providing clarity: The...

Patients with atrial fibrillation should start therapy that controls the heart rhythm as early as possible after diagnosis: This applies to different types of atrial fibrillation, as a sub-study of the EAST-AFNET-4 study has now shown. Patients with atrial fibrillation diagnosed...